Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
8.50    0.00 (0.00%)
Bid:
8.00
Ask:
9.00
Spread: 1.00 (12.50%)
Market Cap: £3.80m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update

9 Jul 2026 07:00

RNS Number : 6014L
Jarvis Securities plc
09 July 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, for a total consideration of up to £11m to Interactive Investor Services Limited (the "Transaction"). The £9m initial consideration was paid to JIML straight away with the remaining £2 million of the consideration deferred for up to c.18 months and subject to potential adjustment for claims under the sale agreement ("Deferred Consideration"), 

The Company is pleased to announce that JIML has now received the first Deferred Consideration payment of £1m plus accrued interest, for a total payment of c.£1,029,000. The second and final Deferred Consideration payment, also of £1m (subject to potential adjustment for claims under the sale agreement) is due on or around 7 January 2027.

At this stage it is intended that JIML will retain these funds during the wind down process after which any surplus will be available for the benefit of the Company, if JIML has not been sold pursuant to the potential sale process announced on 5 May 2026. At this stage there can be no certainty as to the timing of any sale of JIML or that it will occur at all. Full details of the proposed disposal are set out in the Company's announcement of 5 May 2026.

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis Securities plc

 01892 510 515

Andrew Grant

Zeus Capital (Nominated Adviser)

020 3829 5000 

Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSSWFAAEMSEDW
Date   Source Headline
11th Dec 202010:19 amRNSTransaction in Own Shares
10th Nov 20202:56 pmRNSDividend Declaration
29th Oct 20209:30 amRNSResult of EGM
13th Oct 20207:00 amRNSCapital Reorganisation and Notice of EGM
14th Aug 20201:14 pmRNSHolding(s) in Company
6th Aug 20202:10 pmRNSDirector Declaration
30th Jul 20202:06 pmRNSDirector/PDMR Shareholding
21st Jul 202011:49 amRNSDirector/PDMR Shareholding
16th Jul 20204:08 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSHalf-year Report
6th Jul 202012:36 pmRNSBoard Changes
11th Jun 20201:44 pmRNSTransaction in Own Shares
18th May 20203:59 pmRNSDirector/PDMR Shareholding
11th May 20207:00 amRNSInterim Dividend Declaration
30th Apr 20207:00 amRNSTrading Update
23rd Apr 202012:10 pmRNSResult of AGM
14th Apr 20207:00 amRNSLetter to Shareholders
9th Apr 202011:43 amRNSHolding(s) in Company
3rd Apr 202012:56 pmRNSHolding(s) in Company
3rd Apr 202012:55 pmRNSHolding(s) in Company
3rd Apr 202012:53 pmRNSHolding(s) in Company
12th Mar 20207:00 amRNSResults for year ended 31 December 2019
11th Feb 20201:14 pmRNSDividend Declaration
30th Jan 202010:06 amRNSHolding(s) in Company
30th Jan 202010:00 amRNSHolding(s) in Company
30th Jan 20209:57 amRNSHolding(s) in Company
30th Jan 20209:56 amRNSHolding(s) in Company
18th Dec 20194:03 pmRNSHolding(s) in Company
5th Dec 201910:07 amRNSTransaction in Own Shares
26th Nov 20194:37 pmRNSTR1 - Notification of major interest in shares
25th Nov 201912:35 pmRNSDirectors' Interests
5th Nov 201911:37 amRNSDividend Declaration
22nd Oct 20193:36 pmRNSTransaction in Own Shares
17th Sep 201912:05 pmRNSDividend Declaration
5th Sep 20199:28 amRNSTransaction in Own Shares
2nd Aug 201912:22 pmRNSDividend Declaration
18th Jul 20197:00 amRNSHalf-year Report
6th Jun 20193:23 pmRNSDirector/PDMR Shareholding
7th May 201911:37 amRNSDividend Declaration
1st Apr 20193:21 pmRNSTransaction in Own Shares
29th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSFinal Results
30th Jan 20197:00 amRNSDividend Declaration
8th Nov 20187:00 amRNSDividend Declaration
3rd Aug 20182:35 pmRNSDividend Declaration
19th Jul 20187:00 amRNSInterim Results
9th May 201811:15 amRNSDividend Declaration
22nd Mar 20182:30 pmRNSResult of AGM
15th Feb 20187:00 amRNSFinal Results
8th Feb 20187:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.